Alternatives to Dot Compliance

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Cloud-based platform for life sciences companies to manage validation and compliance.

Unleashing the power of genomics at scale for biological advances and human health.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Advanced infectious disease diagnostics

Upcycles food waste into high-value lactic acid using climate-transformative technology.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Accelerating the development of breakthrough new medicines and medical technologies.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Independent investment company and venture builder partnering with the University of Oxford to build businesses.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing novel nitroxide-based therapeutics to treat inflammatory lung diseases.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing novel therapeutic approaches for ocular diseases.

An accelerator program for life science startups.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Developing advanced plant-based ingredients for more resilient and nutritious food systems.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Compliance-by-design execution layer for life sciences enterprises to scale AI.

Provides a unified platform for identity verification, risk assessment, and compliance management.

SaaS platform using AI to optimize insurer solvency capital requirements under Solvency II.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Global provider of integrated temperature-controlled supply chain solutions for the life sciences industry.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

Global leader in life sciences, diagnostics, and applied chemical markets.

Quality management and compliance software for life sciences and other regulated industries.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Life sciences data platform for deep-phenotype multi-omics datasets.